“…In some trials it becomes obvious that mainly male adolescents and adults are affected [56], [57], [58], with a ratio of 3:1 [53], [59]. There are other investigations that do not reveal a gender-related preponderance [49], [52], [53], [55], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68]. The present study confirmed the finding, that patients younger than 19 years of age were predominantly female [53], [55], [58].…”